跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Dexmed
Approved
STANDARD
Dexmed
Gland Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4cafd65258f0e5b7
Company
Gland Pharma Limited
Type
Standard
Approval Details
Approval Id
4cafd65258f0e5b7
Drug Approval Philippines Name
Dexmed
Product Name
Dexmed
Registration Number
DRP-11792
Brand Name
Dexmed
Generic Name
Dexmedetomidine (As Hydrochloride)
Dosage Form
Concentrate Solution for Intravenous Infusion
Dosage Strength
100 mcg/ mL (200 mcg/2 mL)
Manufacturer
Gland Pharma Limited
Importer
Biocare Lifesciences, Inc.
Distributor
Biocare Lifesciences, Inc.
Company Detail Path
/organization/gland-pharma-limited
Issuance Date
29 April 2022
Expiry Date
29 April 2027
Pharmacologic Category
Hypnotic/Sedative
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4cafd65258f0e5b7
Type
Standard
Back to Philippines FDA Approvals
Dexmed - Philippines FDA Drug Approval Details